State Street Corp Candel Therapeutics, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 472,798 shares of CADL stock, worth $3.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
472,798
Previous 27,600
1613.04%
Holding current value
$3.31 Million
Previous $43,000
6716.28%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CADL
# of Institutions
49Shares Held
5.97MCall Options Held
82.9KPut Options Held
56K-
Northpond Ventures, LLC1.94MShares$13.6 Million41.58% of portfolio
-
Black Rock Inc. New York, NY823KShares$5.77 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA819KShares$5.74 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA406KShares$2.84 Million1.27% of portfolio
-
Geode Capital Management, LLC Boston, MA398KShares$2.79 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $203M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...